Targeted Drug Delivery rau Tsev Kho Mob Cancer

Targeted Drug Delivery for Cancer Hospitals: Enhancing Treatment EfficacyTargeted drug delivery systems are revolutionizing cancer treatment, muab kev ua tau zoo dua qub thiab txo cov kev mob tshwm sim rau cov neeg mob. Kab lus no tshawb txog ntau yam kev siv hauv lub hom phiaj xa tshuaj rau cov tsev kho mob qog noj ntshav, tshuaj xyuas lawv cov txheej txheem, qhov zoo, thiab cov nyom. Peb mam li delve rau hauv cov piv txwv tshwj xeeb thiab xav txog yav tom ntej ntawm qhov chaw tseem ceeb hauv oncology.

Nkag siab txog Kev xa tshuaj rau lub hom phiaj

Targeted Drug Delivery yog dab tsi?

Tsis zoo li cov tshuaj chemotherapy, uas faib tshuaj thoob plaws hauv lub cev, lub hom phiaj xa tshuaj rau cov tsev kho mob qog noj ntshav tsom rua kev xa cov kws kho mob ncaj qha rau cov qog nqaij hlav cancer. Txoj hauv kev no txo ​​qis kev puas tsuaj rau cov ntaub so ntswg noj qab haus huv, ua rau muaj kev phiv tsawg dua thiab kho cov txiaj ntsig zoo dua. Ntau txoj hauv kev tau ua haujlwm kom ua tiav qhov kev xa khoom, txhua tus muaj cov yam ntxwv tshwj xeeb thiab kev siv.

Mechanisms ntawm Targeted Drug Delivery

Ob peb mechanisms pab lub hom phiaj xa tshuaj rau cov tsev kho mob qog noj ntshav. Cov no suav nrog:

• Antibody-drug conjugates (ADCs): Cov tshuaj tiv thaiv tshwj xeeb khi rau cov qog nqaij hlav cancer, nqa cov tshuaj txuas ncaj qha mus rau cov qog.
• Liposomal noj tshuaj: Cov tshuaj yog encapsulated nyob rau hauv liposomes, uas yog ces tsom mus rau cov qog nqaij hlav cancer siv cov ligands los yog cov tshuaj tiv thaiv.
• Nanoparticle tshuaj xa khoom: Nanoparticles tuaj yeem tsim los nqa cov tshuaj mus rau qhov chaw qog, uas muaj peev xwm siv cov txiaj ntsig zoo permeability thiab khaws cia (EPR).
• Lub hom phiaj nanoparticles: Cov no siv cov kev hloov kho saum npoo xws li ligands lossis cov tshuaj tiv thaiv kab mob rau cov hom phiaj tshwj xeeb rau cov qog hlwb.

Hom Lub Hom Phiaj Kev Xa Tshuaj

Antibody-Drug Conjugates (ADCs)

ADCs yog ib qho piv txwv tseem ceeb ntawm lub hom phiaj xa tshuaj rau cov tsev kho mob qog noj ntshav. Lawv ua ke qhov tshwj xeeb ntawm monoclonal antibodies nrog lub zog ntawm cov tshuaj cytotoxic. Txoj hauv kev no txhim kho kev ua tau zoo los ntawm kev xa cov tshuaj ncaj qha mus rau cov qog nqaij hlav cancer, thaum ua kom cov nqaij mos noj qab nyob zoo. Piv txwv li, trastuzumab emtansine (Kadcyla) yog ADC siv los kho HER2-zoo mob cancer mis.¹

Liposomal Drug Delivery

Liposomes encapsulate cov tshuaj, tiv thaiv nws los ntawm degradation thiab ua rau nws lub sij hawm ncig hauv cov hlab ntsha. Qhov kev txhim kho pharmacokinetics no tso cai rau lub hom phiaj xa mus rau cov qog nqaij hlav los ntawm cov phiaj xwm ligands lossis kev sib sau ua ke ntawm EPR cov nyhuv. Doxorubicin liposomes (piv txwv li, Doxil) yog ib qho piv txwv pom zoo hauv tsev kho mob.²

Qhov zoo thiab cov teeb meem ntawm Lub Hom Phiaj xa tshuaj

Lub neej yav tom ntej ntawm Targeted Drug Delivery rau Tsev Kho Mob Cancer

Kev tshawb fawb txuas ntxiv ua kom zoo dua thiab nthuav dav qhov muaj peev xwm ntawm lub hom phiaj xa tshuaj rau cov tsev kho mob qog noj ntshav. Kev nce qib hauv nanotechnology, genomics, thiab kev kos duab yog ua rau kev txhim kho cov txheej txheem ntau dua thiab ua tau zoo. Kev koom ua ke ntawm cov tshuaj kho tus kheej thiab kev siv cov kev kho mob sib xyaw ua ke kuj tseem yog txoj hauv kev rau kev txhim kho cov txiaj ntsig hauv kev kho mob qog noj ntshav. Yog xav paub ntxiv txog kev kho mob qog noj ntshav siab thiab kev tshawb fawb, mus saib hauv Shandong Baofa Cancer Research Institute.

¹ FDA. (n.d.). Kadcyla (trastuzumab emtansine). Tau txais los ntawm [https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm361642.htm](https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm361642.htm)

² FDA. (n.d.). DOXIL (doxorubicin HCl liposomal txhaj). Tau txais los ntawm [https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020515](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&051500)